Minocycline versus Doxycycline in the Treatment of Lyme Neuroborreliosis
Author(s) -
Burke A. Cunha
Publication year - 2000
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/313604
Subject(s) - minocycline , medicine , doxycycline , lyme neuroborreliosis , neuroborreliosis , lyme disease , antibiotics , borrelia burgdorferi , microbiology and biotechnology , virology , immunology , antibody , biology
Figure 1. Ratio of CSF: serum concentrations of doxycycline and minocycline after multiple 100-mg oral doses given twice daily. Data are from [11]. trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia. Clin Infect Dis 1998;27:296–302. 3. Walsh T, Bodensteiner D, Hiemenz J, et al. A randomized, double-blind trial of AmBisome (liposomal amphotericin B) versus amphotericin B in the empirical treatment of persistently febrile neutropenic patients [abstract LM-90]. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology, 1997.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom